Can Fite Biopharma Ltd Strategic Asset Allocation Index
Can Fite Biopharma Ltd strategic asset allocation index. Can Fite Biopharma Ltd (CANF) has a Strategic Asset Allocation Index of 1.8% as of June 2023. Strategic assets (PP&E of ILA123.00K plus long-term investments of ILA-) total ILA123.00K, measured against net assets of ILA6.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Can Fite Biopharma Ltd (CANF) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Can Fite Biopharma Ltd (2003–2022)
Strategic asset allocation index of Can Fite Biopharma Ltd from 2003 to 2022. This chart shows how Can Fite Biopharma Ltd's Strategic Asset Allocation Index has evolved across 18 annual periods from 2003 to 2022. As of June 2023, the index stands at 1.8%, representing strategic assets of ILA123.00K against net assets of ILA6.87 Million ILA.
Can Fite Biopharma Ltd Strategic Asset Allocation Index by Year (2003–2022)
Can Fite Biopharma Ltd strategic asset allocation index by year from 2003 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Can Fite Biopharma Ltd from 2003 to 2022, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CANF market cap.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 2.8% | ILA126.00K | ILA126.00K | ILA- | ILA4.47 Million | ▲ +1.5 pp |
| 2021 | 1.3% | ILA185.00K | ILA185.00K | ILA- | ILA14.38 Million | ▼ -0.7 pp |
| 2020 | 2.0% | ILA123.00K | ILA123.00K | ILA- | ILA6.07 Million | ▼ -2.8 pp |
| 2019 | 4.8% | ILA118.00K | ILA118.00K | ILA- | ILA2.44 Million | ▲ +3.3 pp |
| 2018 | 1.6% | ILA47.00K | ILA47.00K | ILA0.00 | ILA3.02 Million | ▼ -29.3 pp |
| 2017 | 30.9% | ILA942.66K | ILA28.00K | ILA914.66K | ILA3.05 Million | ▲ +29.8 pp |
| 2016 | 1.0% | ILA40.00K | ILA40.00K | ILA- | ILA3.87 Million | ▲ +0.5 pp |
| 2015 | 0.6% | ILA60.57K | ILA60.57K | ILA- | ILA10.44 Million | ▼ -1.4 pp |
| 2014 | 1.9% | ILA133.00K | ILA133.00K | ILA- | ILA6.86 Million | ▼ -1.3 pp |
| 2013 | 3.2% | ILA143.00K | ILA143.00K | ILA- | ILA4.46 Million | ▼ -5.2 pp |
| 2011 | 8.4% | ILA278.00K | ILA278.00K | ILA- | ILA3.29 Million | ▲ +4.7 pp |
| 2010 | 3.7% | ILA490.00K | ILA490.00K | ILA- | ILA13.07 Million | ▼ -1.2 pp |
| 2009 | 4.9% | ILA662.00K | ILA662.00K | ILA- | ILA13.49 Million | ▼ -2.0 pp |
| 2008 | 7.0% | ILA1.03 Million | ILA1.03 Million | ILA- | ILA14.79 Million | ▲ +3.6 pp |
| 2007 | 3.3% | ILA1.28 Million | ILA1.28 Million | ILA- | ILA38.70 Million | ▼ -0.9 pp |
| 2006 | 4.2% | ILA1.60 Million | ILA1.60 Million | ILA- | ILA38.34 Million | ▼ -0.6 pp |
| 2005 | 4.7% | ILA1.70 Million | ILA1.70 Million | ILA- | ILA35.83 Million | ▼ -27.6 pp |
| 2003 | 32.4% | ILA670.00K | ILA670.00K | ILA- | ILA2.07 Million | — |